Leif Helth Jensen
Fundador en UV Clinical ApS .
Perfil
Leif Helth Jensen founded Zealand Pharma A in 1998.
Mr. Jensen also founded UV Clinical ApS, where he worked as Chief Executive Officer & Director.
Mr. Jensen also currently works at BluSense Diagnostics ApS, as Chairman and Medi Telecom SA, as Director.
Mr. Jensen also formerly worked at Cureon A, as Chief Executive Officer, Glycom A, as Chief Executive Officer, Botanix Pharmaceuticals Ltd., as Independent Non-Executive Chairman from 2011 to 2012, Valderm ApS, as Chairman from 2011 to 2014, Global Aviation Data A, as Chairman, Microlytic ApS, as Chairman, NTG Nordic Transport Group A, as Director-Pharmacology, Rose Pharma A, as Director, DentoFit A, as Director, Inagen ApS, as Director, Thrombologic ApS, as Director, Alcorlab A, as Director, DENCORE ApS, as Director, Veloxis Pharmaceuticals A, as Vice President-Portfolio Management, and CAT Management ApS, as Investment Manager from 2006 to 2012.
Mr. Jensen received his graduate degree from the University of Copenhagen.
Cargos activos de Leif Helth Jensen
| Empresas | Cargo | Inicio |
|---|---|---|
Medi Telecom SA
 Medi Telecom SA Wireless TelecommunicationsCommunications Medi Telecom SA engages in the provision of wireless telecommunications services. The company was founded in 1999 and is headquartered in Casablanca, Morocco. | Director/Miembro de la Junta | 17/03/2011 |
BluSense Diagnostics ApS
 BluSense Diagnostics ApS Medical SpecialtiesHealth Technology BluSense Diagnostics ApS develops medical devices through connecting to cloud software. It offers BluBox, Viro-Track, and nanotechnology and microfluidics. The company was founded by Marco Donolato in 2014 and is headquartered in Copenhagen, Denmark. | Presidente | - |
UV Clinical ApS
 UV Clinical ApS SemiconductorsElectronic Technology UV Clinical ApS is a technology company, which engages in the development of devices using ultra-violet light emitting diodes for disinfection of medical implants. The company was founded by Leif Helth Jensen and Jimmy Bak and is headquartered in Greve, Denmark. | Fundador | - |
Antiguos cargos conocidos de Leif Helth Jensen.
| Empresas | Cargo | Fin |
|---|---|---|
Valderm ApS
 Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Presidente | 21/05/2014 |
Thrombologic ApS
 Thrombologic ApS Miscellaneous Commercial ServicesCommercial Services Thrombologic ApS provides medical research and develops therapeutics. The firm develops a new therapy for prevention and treatment of multiple organ failure in Intensive care unit (ICU) patients. The company was founded in December 2009 and is headquartered in Copenhagen, Denmark. | Director/Miembro de la Junta | 20/03/2014 |
DentoFit A/S
 DentoFit A/S Medical SpecialtiesHealth Technology DentoFit A/S develops non-shrinking composite resin material for dental plastic fillings. Its material is used as filler for dental restorative therapy. The company was founded by Per Bækgård in 2004 and is headquartered in Roskilde, Denmark. | Director/Miembro de la Junta | 27/01/2014 |
CAT Management ApS
 CAT Management ApS Investment ManagersFinance CAT Management ApS is a Venture Capital firm, a subsidiary of Capnova A/S founded in 1998. CAT Management ApS is headquartered in Roskilde. | Inversor de Capital Privado | 31/12/2012 |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Director/Miembro de la Junta | 27/06/2012 |
Formación de Leif Helth Jensen.
| University of Copenhagen | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
| NTG NORDIC TRANSPORT GROUP A/S | Transportation |
| ZEALAND PHARMA A/S | Health Technology |
| Empresas privadas | 16 |
|---|---|
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Health Technology |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Health Technology |
CAT Management ApS
CAT Management ApS Investment ManagersFinance CAT Management ApS is a Venture Capital firm, a subsidiary of Capnova A/S founded in 1998. CAT Management ApS is headquartered in Roskilde. | Finance |
Inagen ApS
 Inagen ApS Miscellaneous Commercial ServicesCommercial Services Inagen ApS is a holding company that develops novel biopharmaceuticals for anti-viral treatment opportunities. Its primary candidate is treatment for Cytomegalovirus (CMV). The technology utilizes a "self targeting capability", which takes place in the natural defense mechanism of the specific disease, to target and kill infected cells. Its platform technology can be utilized to target numerous infectious diseases. The company was founded by Thomas Nitschke Kledal l in 2007 and is headquartered in Lyngby, Denmark. | Commercial Services |
Microlytic ApS
 Microlytic ApS Medical SpecialtiesHealth Technology Microlytic ApS provided structural biology laboratories equipment. It developed its technology solutions to address issues in the structural biology. The company was founded by Morten Otto Alexander Sommer in 2006 and headquartered in Roskilde, Denmark. | Health Technology |
Dencore ApS
 Dencore ApS Industrial MachineryProducer Manufacturing Dencore ApS is a holding company that manufactures packaging machines for the diagnostic, biotech, and pharmaceutical sectors. Its products include Microtube Filling and Capping Systems, Microtube Capping Systems, and Microtube Labelling Systems. It also offers IQ, OQ, and PQ documentation, installation and equipment training, and on site service and repair. The company was founded by Jens Agerskov in 2010 and is headquartered in Jyllinge, Denmark. | Producer Manufacturing |
Cureon A/S
 Cureon A/S Pharmaceuticals: MajorHealth Technology Cureon A/S is a Danish biotech company that owns the pharmaceutical rights to a novel DNA analogue, termed LNA (Locked Nucleic Acid) which displays unprecedented affinity compared to all other DNA chemistries. The company believes that the unique properties of this novel analogue will enable oligonucleotide based therapeutics (Antisense therapy) to enter main-stream pharmaceuticals. | Health Technology |
Valderm ApS
Valderm ApS Pharmaceuticals: MajorHealth Technology Valderm ApS is focused on the development of the second generation anthracycline valrubicin for innovative once daily topical treatment of hyper proliferative skin diseases e.g. psoriasis. Preclinical studies have confirmed the anti-proliferative effect of valrubicin and an attractive safety profile upon repeated topical applications has been documented. The company was founded in 2003 and is headquartered in Lyngby, Denmark. | Health Technology |
Medi Telecom SA
Medi Telecom SA Wireless TelecommunicationsCommunications Medi Telecom SA engages in the provision of wireless telecommunications services. The company was founded in 1999 and is headquartered in Casablanca, Morocco. | Communications |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Alcorlab A/S
 Alcorlab A/S Chemicals: SpecialtyProcess Industries Alcorlab A/S manufactures peptide synthesizers. It develops an apparatus that can synthesize oligonucleotides, LNA´s, DNA's, RNA's, and peptides. The company is headquartered in Vaerloese, Denmark. | Process Industries |
Global Aviation Data A/S
 Global Aviation Data A/S Electronic Equipment/InstrumentsElectronic Technology Global Aviation Data A/S develops system for managing the risk of overexposure to cosmic radiation during air transportation. Its system is designed to help frequent flyers and airlines to manage and minimize their risk of overexposure to radiation. The firm also handles the administrative and reporting procedures necessary to comply with existing and future national and international legislation and regulation concerning cosmic radiation. The company was founded by Peer Widar Wollenberg on July 4, 2003 and is headquartered in Klampenborg, Denmark. | Electronic Technology |
Thrombologic ApS
Thrombologic ApS Miscellaneous Commercial ServicesCommercial Services Thrombologic ApS provides medical research and develops therapeutics. The firm develops a new therapy for prevention and treatment of multiple organ failure in Intensive care unit (ICU) patients. The company was founded in December 2009 and is headquartered in Copenhagen, Denmark. | Commercial Services |
DentoFit A/S
DentoFit A/S Medical SpecialtiesHealth Technology DentoFit A/S develops non-shrinking composite resin material for dental plastic fillings. Its material is used as filler for dental restorative therapy. The company was founded by Per Bækgård in 2004 and is headquartered in Roskilde, Denmark. | Health Technology |
BluSense Diagnostics ApS
BluSense Diagnostics ApS Medical SpecialtiesHealth Technology BluSense Diagnostics ApS develops medical devices through connecting to cloud software. It offers BluBox, Viro-Track, and nanotechnology and microfluidics. The company was founded by Marco Donolato in 2014 and is headquartered in Copenhagen, Denmark. | Health Technology |
UV Clinical ApS
UV Clinical ApS SemiconductorsElectronic Technology UV Clinical ApS is a technology company, which engages in the development of devices using ultra-violet light emitting diodes for disinfection of medical implants. The company was founded by Leif Helth Jensen and Jimmy Bak and is headquartered in Greve, Denmark. | Electronic Technology |
- Bolsa de valores
- Insiders
- Leif Helth Jensen
